Drug intelligence / Profile preview

Hyalolex

Development stage
Preclinical
Lead developer
IGC Pharma
Modality
Small Molecules
Administration
Oral
01

Overview

**Hyalolex** is a proprietary oral cannabinoid-based combination supplement developed by India Globalization Capital for symptoms associated with Alzheimer's disease, including behavioral and psychological symptoms such as anxiety, aggression, and sleep disturbance. The company identified the original Alzheimer's-focused formulation as **IGC-507** and described it as an FDA-unapproved alternative oral combination therapy based on research licensed from the University of South Florida. Public company materials do not sufficiently disclose the complete, fixed active-ingredient composition of the original Hyalolex formulation to assign a definitive molecular mechanism. ([investor.igcpharma.com](https://investor.igcpharma.com/wp-content/uploads/2023/01/IGC-FilesPatentforHyalolexFormulation.pdf))

Brand names
HyalolexHyalolex Drops of Clarity
02

Targets

GSK3 (Glycogen synthase kinase 3 beta)Aβ (Amyloid-beta peptides and aggregates)MAPT (Microtubule-associated protein tau)

Beyond the preview

Go deeper on Hyalolex.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hyalolex.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call